| | Reviews Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension M Kathryn Steiner and Ioana R Preston Vasc Health Risk Manag. 2008 October; 4(5): 943–952. PMCID: PMC2605321 Excess coronary artery disease risk in South Asian immigrants: Can dysfunctional high-density lipoprotein explain increased risk? Sunita Dodani Vasc Health Risk Manag. 2008 October; 4(5): 953–961. PMCID: PMC2605339 Habitual coffee consumption and blood pressure: An epidemiological perspective Johanna M Geleijnse Vasc Health Risk Manag. 2008 October; 4(5): 963–970. PMCID: PMC2605331 The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Giorgio Gentile, and Gianpaolo Reboldi Vasc Health Risk Manag. 2008 October; 4(5): 971–981. PMCID: PMC2605336 Clinical use of parnaparin in major and minor orthopedic sugery: a review Stefano Bugamelli, Elena Zangheri, Milena Montebugnoli, and Lucia Guerra Vasc Health Risk Manag. 2008 October; 4(5): 983–990. PMCID: PMC2605328 Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing Michel Farnier Vasc Health Risk Manag. 2008 October; 4(5): 991–1000. PMCID: PMC2605343 Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin Anbu Pandian, Anjali Arora, Laurence S Sperling, and Bobby V Khan Vasc Health Risk Manag. 2008 October; 4(5): 1001–1009. PMCID: PMC2605342 Effects of study design and trends for EVAR versus OSR Robert Hopkins, James Bowen, Kaitryn Campbell, Gord Blackhouse, Guy De Rose, Teresa Novick, Daria O’Reilly, Ron Goeree, and Jean-Eric Tarride Vasc Health Risk Manag. 2008 October; 4(5): 1011–1022. PMCID: PMC2605334 Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities Todd C Rideout, Scott V Harding, Peter JH Jones, and Ming Z Fan Vasc Health Risk Manag. 2008 October; 4(5): 1023–1033. PMCID: PMC2605338 Current concepts in the management of hepatopulmonary syndrome Vincent Ho Vasc Health Risk Manag. 2008 October; 4(5): 1035–1041. PMCID: PMC2605324 Arterial pulmonary hypertension in noncardiac intensive care unit Mykola V Tsapenko, Arseniy V Tsapenko, Thomas BO Comfere, Girish K Mour, Sunil V Mankad, and Ognjen Gajic Vasc Health Risk Manag. 2008 October; 4(5): 1043–1060. PMCID: PMC2605326 The importance of endothelin-1 for microvascular dysfunction in diabetes Majid Kalani Vasc Health Risk Manag. 2008 October; 4(5): 1061–1068. PMCID: PMC2605330 Single photon emission computed tomography: An alternative imaging modality in left ventricular evaluation Hulya Yalçin, Sofiane Maza, and Fatih Yalçin Vasc Health Risk Manag. 2008 October; 4(5): 1069–1072. PMCID: PMC2605329 Original Research ST segment depression in hypertensive patients: A comparison of exercise test versus Holter ECG Sakir Uen, Rolf Fimmers, Burkhard Weisser, Osman Balta, Georg Nickenig, and Thomas Mengden Vasc Health Risk Manag. 2008 October; 4(5): 1073–1080. PMCID: PMC2605337 Postpartum thromboembolism: Severe events might be preventable using a new risk score model Pelle G Lindqvist, Jelena Torsson, Åsa Almqvist, and Ola Björgell Vasc Health Risk Manag. 2008 October; 4(5): 1081–1087. PMCID: PMC2605344 Frequency of secondary dyslipidemia in obese children Ulrike Korsten-Reck, Katrin Kromeyer-Hauschild, Katrin Korsten, Manfred W Baumstark, Hans-H Dickhuth, and Aloys Berg Vasc Health Risk Manag. 2008 October; 4(5): 1089–1094. PMCID: PMC2605332 The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene Yong Zhang and Kenneth S Ramos Vasc Health Risk Manag. 2008 October; 4(5): 1095–1102. PMCID: PMC2605340 Compliance of the aorta in two diseases affecting vascular elasticity, familial hypercholesterolemia and diabetes: a MRI study Sami Soljanlahti, Taina Autti, Laura Hyttinen, Alpo F Vuorio, Pekka Keto, and Kirsi Lauerma Vasc Health Risk Manag. 2008 October; 4(5): 1103–1109. PMCID: PMC2605333 Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension Anne M Keogh, Andrew Jabbour, Christopher S Hayward, and Peter S Macdonald Vasc Health Risk Manag. 2008 October; 4(5): 1111–1113. PMCID: PMC2605335 Under- and overreporting of energy in a group of candidates for CABG surgery and its association with some anthropometric and sociodemographic factors, Tehran, Iran Bahareh Amirkalali, Mehdi Najafi, Asal Ataie-Jafari, Saeed Hosseini, and Ramin Heshmat Vasc Health Risk Manag. 2008 October; 4(5): 1115–1120. PMCID: PMC2605341 Validation of the Oregon Scientific BPU 330 for self-monitoring of blood pressure according to the International Protocol Li Li, XinYu Zhang, ChunHong Yan, and QingXiang Liang Vasc Health Risk Manag. 2008 October; 4(5): 1121–1125. PMCID: PMC2605325 Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience Glen J Pearson, Kari L Olson, Nicole E Panich, Sumit R Majumdar, Ross T Tsuyuki, Dawna M Gilchrist, Ali Damani, Gordon A Francis, and The MILLARR Study (Maintenance of Improved Lipid Levels Following Attendance at a Cardiovascular Risk Reduction Clinic) Vasc Health Risk Manag. 2008 October; 4(5): 1127–1135. PMCID: PMC2605345 Case Reports Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study Toshiyuki Oshitari, Noriko Asaumi, Masaru Watanabe, Ken Kumagai, and Yoshinori Mitamura Vasc Health Risk Manag. 2008 October; 4(5): 1137–1140. PMCID: PMC2605323 Aberrant positioning of a central venous dialysis catheter to reveal a left-sided partial anomalous pulmonary venous connection Manohar R Chintu, Shammikumar Chinnappa, and Sunil Bhandari Vasc Health Risk Manag. 2008 October; 4(5): 1141–1143. PMCID: PMC2605322 ISVH Society News ISVH – October Newsletter David Oldfield and Prof. Roland Asmar Vasc Health Risk Manag. 2008 October; 4(5): 1145–1146. PMCID: PMC2605327 |